OKKO Masterclass 360 2019
Date: 17/03/2019
Venue: Brisbane Convention Centre Grey St South Brisbane , QLD, 4101
Provider: OKKO Eye Specialist Centre
Contact: Narelle Murphy, [E] info@okko.com.au, [P] 07 37250222
Learning Objectives
- Understand the importance and context of glaucoma diagnosis and co-management within the Australian healthcare landscape.
- Understand key elements and common pitfalls in glaucoma diagnosis.
- Select appropriate initial management strategies for glaucoma.
- Understand key factors in glaucoma monitoring.
- Implement appropriate communication and referral pathways to ensure optimum patient care.
- Understand the range of corneal ecstatic disorders and their impact on patients
- Understand the risk factors for corneal ectasia and progression as well as associated conditions
- Be able to initiate appropriate lifestyle and medical management strategies for corneal ectasia patients
- Understand the indications for surgical treatments for corneal ectasia
- How to evaluate a ptosis patient and indications for ptosis repair
- How to evaluate a dermatochalasis patient and indications for dermatochalsis repair
- Functional versus. cosmetic blepharoplasty procedures
- The features of benign versus malignant eyelid lesions
- Topical and systemic therapeutic considerations involved in oculoplastic eyelid surgery
- To recognise key features of age-related macular degeneration (AMD) on both clinical examination and diagnostic imaging, and to differentiate this from other macular disease
- To become familiar with the different stages of AMD according to the Age-Related Eye Disese Study (AREDS) Grading System
- To become familiar with the different stages of AMD according to the Age-Related Eye Disese Study (AREDS) Grading System
- To identify the key constituents of the current AREDS2 anti-oxidant formulation and recognising when nutritional supplements might be indicated
- To have a working understanding of current and future diagnostic and treatment options for AMD
- How to evaluate currently available the medical evidence for controversial general medical treatments
- How to evaluate communicate the currently available the medical evidence for controversial general medical treatments to patients
- To understand the impact of co-existing glaucoma and anterior segment disease on cataract surgery
- To become familiar with the appropriate use of antivirals in patients with Herpetic eye disease undergoing cataract surgery
- To understand the impact of corneal ectasia on biometry
- To be aware of the impact of cosmetic procedures on ocular surface
- To understand various presentations & management options for ocular surface squamous neoplasias
- To understand therapeutic and surgical management options for complex glaucomas
- To understand the nature, complexity and role of the microbiome
- To understand the role of genes and environment in regulating the ocular microbiome
- To understand the role of the ocular microbiome in ocular health and disease
- To understand the role/s of ocular therapeutic agents before, during and after cataract surgery and their influence on the ocular microbiome
- To understand the benefits of ocular therapeutic agents before, during and after cataract surgery
- To understand the adverse effects of ocular and systemic therapeutic agents before, during and after cataract surgery
Max points awarded: 22.00
Session Information
| Name |
|---|
| Cataract Surgery Challenges Approaching 2020 |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| Yes |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 2.25 |
| Name |
|---|
| Impact of Glaucoma & Anterior Segment Diseases on Cataract Surgery |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| Yes |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 2.25 |
| Name |
|---|
| Common Eyelid Problems and their Therapeutic Management |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| Yes |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 2.25 |
| Name |
|---|
| Glaucoma Shared Care: Tips for Safe, Effective Co-management |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| Yes |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 2.25 |
| Name |
|---|
| A Matter of Drusen |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| Yes |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 2.25 |
| Name |
|---|
| Current Controversies in Evidence-based Consumer Health Care and the Advocacy Role of the Allied Health Care Practitioner |
| Activity Type |
|---|
| Face to Face without Assessment |
| Therapeutic? |
|---|
| Yes |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 1.00 |
| Name |
|---|
| Q&A session – The Microbiome and Ocular Health & Disease |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| Yes |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 3.00 |
| Name |
|---|
| Challenging Glaucoma & Anterior Segment Cases |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| Yes |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 3.00 |
| Name |
|---|
| Corneal Ectasia: Modern Management of a Widening Array of Indications |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| Yes |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 2.25 |
| Name |
|---|
| Glaucoma Australia Update |
| Activity Type |
|---|
| Face to Face with Assessment |
| Therapeutic? |
|---|
| Yes |
| Manufacturer/Supplier? |
|---|
| No |
| Points for attending & Passing Assessment |
|---|
| 1.50 |
| Name | Activity Type | Therapeutic? | Manufacturer/
Supplier? | Points for attending &
Passing Assessment |
|---|
| Cataract Surgery Challenges Approaching 2020 | Face to Face with Assessment | Yes | No | 2.25 |
| Impact of Glaucoma & Anterior Segment Diseases on Cataract Surgery | Face to Face with Assessment | Yes | No | 2.25 |
| Common Eyelid Problems and their Therapeutic Management | Face to Face with Assessment | Yes | No | 2.25 |
| Glaucoma Shared Care: Tips for Safe, Effective Co-management | Face to Face with Assessment | Yes | No | 2.25 |
| A Matter of Drusen | Face to Face with Assessment | Yes | No | 2.25 |
| Current Controversies in Evidence-based Consumer Health Care and the Advocacy Role of the Allied Health Care Practitioner | Face to Face without Assessment | Yes | No | 1.00 |
| Q&A session – The Microbiome and Ocular Health & Disease | Face to Face with Assessment | Yes | No | 3.00 |
| Challenging Glaucoma & Anterior Segment Cases | Face to Face with Assessment | Yes | No | 3.00 |
| Corneal Ectasia: Modern Management of a Widening Array of Indications | Face to Face with Assessment | Yes | No | 2.25 |
| Glaucoma Australia Update | Face to Face with Assessment | Yes | No | 1.50 |